MUFA-SIRT1 signaling as a central node regulating healthspan
MUFA-SIRT1 signaling as a central node regulating healthspan
批准号:
10711019
负责人:
Douglas G Mashek
金额:
$31.76万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-09-15 至 2025-05-31
关键词:
AgingAlzheimer disease preventionAlzheimer&aposs disease related dementiaBiologyBrainCaloric RestrictionClinical TrialsCognitionConsumptionDataDevelopmentDietDietary FactorsDietary FatsDietary InterventionDiseaseEatingFastingGleanHealthHealth BenefitHumanImpaired cognitionImpairmentIntervention StudiesLaboratoriesLinkLipolysisMediatingMediterranean DietMonounsaturated Fatty AcidsMusNerve DegenerationNervous System PhysiologyNeurodegenerative DisordersNeurologicNeurophysiology - biologic functionNutritionalOilsOlive oil preparationOutcomePathologyPathway interactionsPatternPhenolsProteinsSIRT1 geneSignal TransductionTestingTherapeuticaging braindetection of nutrientepidemiology studyhealthspanimprovedlipid metabolismmiddle agenovel therapeuticspreclinical trialpreventsmall molecule
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Diet is a major regulator of most if not all aging-related diseases. The Mediterranean Diet is widely regarded
as the gold standard of diets due to its ability to reduce a wide range of aging-related diseases resulting in
improved healthspan. While numerous components of the Mediterranean Diet likely contribute to its health
benefits, extra virgin olive oil has emerged as a major constituent underlying these effects. Indeed, both
epidemiological and interventional studies have linked extra virgin olive oil consumption to improved health
benefits including reductions in cognitive decline and neurodegenerative diseases. Extra virgin olive oil is
largely comprised of oil enriched in monounsaturated fatty acids (MUFA) as well as a diverse class of phenolic
compounds. Interestingly, both MUFAs and the many phenols found in extra virgin olive oil have been shown
in pre-clinical and clinical trials to have positive effects on cognition and in the prevention of Alzheimer’s
Disease and related dementias. Our laboratory has found the MUFAs are allosteric activators of sirtuin 1
(SIRT1), a key nutrient sensing protein that regulates a plethora of pathways controlling aging-related
pathologies. Numerous phenols, including some found in extra virgin olive oil, also can activate SIRT1 to
improve aging related outcomes and, as we have shown, these small molecules likely activate SIRT1 through
the same mechanism as MUFAs. Thus, deciphering the health benefits of MUFAs vs non-lipid components
in olive oil, and the extent to which SIRT1 allosteric activation mediates these effects, would greatly advance
our understanding of the Mediterranean Diet, the health benefits of olive oil, and SIRT1 biology. In addition,
MUFA signaling to SIRT1 occurs upon conditions that stimulate lipolysis such as fasting or caloric restriction
suggesting that diet composition and eating patterns are co-dependent. Based upon these data, we
hypothesize that MUFAs and extra virgin olive oil phenols will prevent declines in cognition and neurological
impairments via SIRT1 activation and will modulate the effects of caloric restriction. To test our hypothesis,
we will conduct the following two aims. 1) To test the effects of extra virgin olive oil MUFAs and phenols
signaling via SIRT1 on aging-related neurodegeneration. In this aim, we will feed wild-type or SIRT1 E222K
mice, which lack responsiveness to SIRT1 allosteric activators, diets enriched in olive oil with high or low
phenolic content and comprehensively characterize neurological function and cognition. 2) To determine
impact of olive oil and caloric restriction alone or in combination on neurodegeneration. We will feed middle-
aged mice diets with low or high MUFA along under ad libitum or caloric restriction conditions to determine if
the interaction between these two dietary interventions impacts cognition and neural function. We expect
these studies to advance our understanding into how dietary lipids and caloric restriction impact the aging
brain, which will help define new mechanisms underlying neurodegenerative diseases and open new
therapeutic avenues targeting lipid metabolism.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lipid droplets and the compartmentalization of subcellular metabolism
-
批准号:10589330
-
项目类别:
-
资助金额:$34.49万
-
财政年份:2023
-
负责人:Douglas G Mashek
-
依托单位:
MUFA-SIRT1 signaling as a central node regulating healthspan
-
批准号:10646427
-
项目类别:
-
资助金额:$31.78万
-
财政年份:2020
-
负责人:Douglas G Mashek
-
依托单位:
MUFA-SIRT1 signaling as a central node regulating healthspan
-
批准号:10432079
-
项目类别:
-
资助金额:$31.78万
-
财政年份:2020
-
负责人:Douglas G Mashek
-
依托单位:
MUFA-SIRT1 signaling as a central node regulating healthspan
-
批准号:10263268
-
项目类别:
-
资助金额:$31.76万
-
财政年份:2020
-
负责人:Douglas G Mashek
-
依托单位:
MUFA-SIRT1 signaling as a central node regulating healthspan
-
批准号:10092409
-
项目类别:
-
资助金额:$31.57万
-
财政年份:2020
-
负责人:Douglas G Mashek
-
依托单位:
Regulation and consequences of hepatic lipid droplet catabolism
-
批准号:9926393
-
项目类别:
-
资助金额:$6.23万
-
财政年份:2017
-
负责人:Douglas G Mashek
-
依托单位:
Role of ATGL and lipid metabolism in healthspan
-
批准号:9902277
-
项目类别:
-
资助金额:$31.88万
-
财政年份:2017
-
负责人:Douglas G Mashek
-
依托单位:
Role of ATGL and lipid metabolism in healthspan
-
批准号:9285055
-
项目类别:
-
资助金额:$32.58万
-
财政年份:2017
-
负责人:Douglas G Mashek
-
依托单位:
Regulation and consequences of hepatic lipid droplet catabolism
-
批准号:9366252
-
项目类别:
-
资助金额:$37.68万
-
财政年份:2017
-
负责人:Douglas G Mashek
-
依托单位:
Role of ATGL and lipid metabolism in healthspan
-
批准号:9344823
-
项目类别:
-
资助金额:$19.83万
-
财政年份:2016
-
负责人:Douglas G Mashek
-
依托单位:
Synergistic effects of diet, lipolytic signaling and SIRT1 on energy metabolism
-
批准号:9076468
-
项目类别:
-
资助金额:$37.11万
-
财政年份:2016
-
负责人:Douglas G Mashek
-
依托单位:
Role of ATGL in hepatic energy metabolism
-
批准号:8280419
-
项目类别:
-
资助金额:$32.39万
-
财政年份:2011
-
负责人:Douglas G Mashek
-
依托单位:
Role of ATGL in hepatic energy metabolism
-
批准号:8489292
-
项目类别:
-
资助金额:$31.01万
-
财政年份:2011
-
负责人:Douglas G Mashek
-
依托单位:
Role of ATGL in hepatic energy metabolism
-
批准号:8849899
-
项目类别:
-
资助金额:$32.09万
-
财政年份:2011
-
负责人:Douglas G Mashek
-
依托单位:
Role of ATGL in hepatic energy metabolism
-
批准号:8113726
-
项目类别:
-
资助金额:$37.99万
-
财政年份:2011
-
负责人:Douglas G Mashek
-
依托单位:
Role of ATGL in lipid droplet and nuclear lipidomes
-
批准号:8635172
-
项目类别:
-
资助金额:$13.78万
-
财政年份:2011
-
负责人:Douglas G Mashek
-
依托单位:
ATGL: Major regulator of hepatic steatosis and energy metabolism
-
批准号:8038526
-
项目类别:
-
资助金额:$21.89万
-
财政年份:2010
-
负责人:Douglas G Mashek
-
依托单位:
Acyl-CoA Synthetase Isoforms in Hepatic Lipid Metabolism
-
批准号:6835023
-
项目类别:
-
资助金额:$4.3万
-
财政年份:2004
-
负责人:Douglas G Mashek
-
依托单位:
Acyl-CoA Synthetase Isoforms in Hepatic Lipid Metabolism
-
批准号:6949623
-
项目类别:
-
资助金额:$3.09万
-
财政年份:2004
-
负责人:Douglas G Mashek
-
依托单位:
海外基金